Brand family
Segluromet
Ertugliflozin pidolate and Metformin and Ertugliflozin and Metformin · Merck Sharp & Dohme
European UnionUnited States
- Presentations
- 4
- Markets
- 2
Segluromet is a brand of Ertugliflozin pidolate and Metformin and Ertugliflozin and Metformin marketed by Merck Sharp & Dohme, with 4 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ertugliflozin pidolate and Metformin, Ertugliflozin and Metformin
- Brand owner
- Merck Sharp & Dohme
- Registered in
- European Union, United States
- Strengths and forms
- 2.5 mg/1000 mg tablet, 2.5 mg/500 mg tablet, 7.5 mg/1000 mg tablet, 7.5 mg/500 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Segluromet 2.5 mg/1000 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Segluromet 2.5 mg/500 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Segluromet 7.5 mg/1000 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Segluromet 7.5 mg/500 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Segluromet
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.